Correlation Between Okta and Virpax Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Okta and Virpax Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Okta and Virpax Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Okta Inc and Virpax Pharmaceuticals, you can compare the effects of market volatilities on Okta and Virpax Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Okta with a short position of Virpax Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Okta and Virpax Pharmaceuticals.
Diversification Opportunities for Okta and Virpax Pharmaceuticals
0.31 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Okta and Virpax is 0.31. Overlapping area represents the amount of risk that can be diversified away by holding Okta Inc and Virpax Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Virpax Pharmaceuticals and Okta is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Okta Inc are associated (or correlated) with Virpax Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Virpax Pharmaceuticals has no effect on the direction of Okta i.e., Okta and Virpax Pharmaceuticals go up and down completely randomly.
Pair Corralation between Okta and Virpax Pharmaceuticals
Given the investment horizon of 90 days Okta Inc is expected to generate 0.26 times more return on investment than Virpax Pharmaceuticals. However, Okta Inc is 3.85 times less risky than Virpax Pharmaceuticals. It trades about 0.12 of its potential returns per unit of risk. Virpax Pharmaceuticals is currently generating about 0.0 per unit of risk. If you would invest 7,216 in Okta Inc on August 24, 2024 and sell it today you would earn a total of 329.00 from holding Okta Inc or generate 4.56% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Okta Inc vs. Virpax Pharmaceuticals
Performance |
| Timeline |
| Okta Inc |
| Virpax Pharmaceuticals |
Okta and Virpax Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Okta and Virpax Pharmaceuticals
The main advantage of trading using opposite Okta and Virpax Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Okta position performs unexpectedly, Virpax Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Virpax Pharmaceuticals will offset losses from the drop in Virpax Pharmaceuticals' long position.The idea behind Okta Inc and Virpax Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| Virpax Pharmaceuticals vs. Revelation Biosciences | Virpax Pharmaceuticals vs. Palisade Bio | Virpax Pharmaceuticals vs. Virax Biolabs Group | Virpax Pharmaceuticals vs. Quoin Pharmaceuticals Ltd |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Complementary Tools
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |